U.S. markets closed

iRhythm Technologies, Inc. (IRTC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
252.74+0.86 (+0.34%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close251.88
Bid252.23 x 800
Ask252.96 x 1400
Day's Range245.67 - 256.56
52 Week Range56.54 - 282.64
Avg. Volume404,448
Market Cap7.297B
Beta (5Y Monthly)1.67
PE Ratio (TTM)N/A
EPS (TTM)-1.89
Earnings DateFeb 25, 2021 - Mar 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est244.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Why iRhythm Technologies Stock Skyrocketed 248% in 2020
    Motley Fool

    Why iRhythm Technologies Stock Skyrocketed 248% in 2020

    Shares of iRhythm Technologies (NASDAQ: IRTC), which makes wearable biosensors for detecting cardiac arrhythmias, soared 248% in 2020, according to data from S&P Global Market Intelligence. It's down 6.5% through Jan. 7, whereas the broader market has returned 2% over this period.

  • iRhythm Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

    iRhythm Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

    SAN FRANCISCO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Tuesday, January 12, 2021 at 2:50 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: www.irhythmtech.com.About iRhythm Technologies, Inc. iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.Investor Relations Contact Lynn Pieper Lewis or Leigh Salvo (415) 937-5404 investors@irhythmtech.com Media Contact Saige Smith   (262) 289-7065 irhythm@highwirepr.com

  • Is iRhythm Technologies (IRTC) a Smart Long-term Buy?
    Insider Monkey

    Is iRhythm Technologies (IRTC) a Smart Long-term Buy?

    Brown Capital Management Small Company Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 5.35% (instl. class) for the quarter, underperforming its benchmark, the Russell 2,000 Growth Index which returned 7.16% in the same quarter. You should check out Brown Capital Management’s […]